STEPHANIE SUE WHITE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health MARSHALL, TX NPI 1093476798

General Payments — all program years on this page

$1,101.45

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 57
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $361.53 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $361.5320

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $359.9818
2023 $379.9419
2024 $361.5320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078208473 Janssen Pharmaceuticals, Inc $14.04 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101238588 E.R. Squibb & Sons, L.L.C. $21.27 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101238606 E.R. Squibb & Sons, L.L.C. $15.75 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101238624 E.R. Squibb & Sons, L.L.C. $16.14 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119213069 Otsuka America Pharmaceutical, Inc. $19.56 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120619476 Alkermes, Inc. $13.40 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143627320 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.66 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143627322 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.05 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146106451 Lundbeck LLC $15.94 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147863031 Supernus Pharmaceuticals, Inc. $13.30 11/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147863033 Supernus Pharmaceuticals, Inc. $13.43 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147863035 Supernus Pharmaceuticals, Inc. $19.05 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150946841 Neurocrine Biosciences, Inc. $27.35 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150950307 Neurocrine Biosciences, Inc. $26.32 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150955249 Neurocrine Biosciences, Inc. $24.99 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150967251 Neurocrine Biosciences, Inc. $22.40 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150972641 Neurocrine Biosciences, Inc. $21.44 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151000458 Neurocrine Biosciences, Inc. $15.84 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151017015 Neurocrine Biosciences, Inc. $8.33 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151677749 Teva Pharmaceuticals USA, Inc. $20.27 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.